Literature DB >> 19675218

Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia.

Remco P H Peters1, Richard F de Boer, Tim Schuurman, Sonja Gierveld, Mirjam Kooistra-Smid, Michiel A van Agtmael, Christina M J E Vandenbroucke-Grauls, Maike C J Persoons, Paul H M Savelkoul.   

Abstract

Direct detection of Streptococcus pneumoniae DNA in blood adds to culture results in the etiological diagnosis of patients with community-acquired pneumonia (CAP). Quantification of the amount of DNA, the bacterial DNA load (BDL), provides a measurement of DNAemia that may increase the understanding of the clinical relevance of S. pneumoniae DNA in blood. We evaluated the S. pneumoniae BDL as a diagnostic tool in adult patients with CAP. The BDL was determined in whole-blood samples collected simultaneously with blood for culture from 45 adult patients with CAP. After DNA extraction, S. pneumoniae DNA was detected with specific real-time PCR amplification, and the BDL was calculated with a standard curve. PCR and microbiological results were compared, and the BDL was related to clinical and laboratory parameters. S. pneumoniae DNA was detected in 10/13 patients with positive blood cultures and in 67% of patients with microbiologically confirmed pneumococcal pneumonia. The positive predictive values of the receiver operating characteristic curves for the BDLs for pneumococcal infection (100%) and pneumococcal bacteremia (69%) were higher than those for the level of C-reactive protein (CRP; 43% and 23%, respectively) and the white blood cell count (WBC; 42% and 35%, respectively); the negative predictive values of these three parameters were in the same range (+/-90 and +/-97%, respectively). The BDL was higher in patients presenting with systemic inflammatory response syndrome and in patients with bacteremia. Positive correlations were observed for the BDL with WBC, CRP level, and length of stay. We conclude that the BDL supports the diagnosis of S. pneumoniae infection in patients with CAP and provides a putative marker of the severity of disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675218      PMCID: PMC2756912          DOI: 10.1128/JCM.01071-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia.

Authors:  R Theerthakarai; W El-Halees; M Ismail; R A Solis; M A Khan
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study.

Authors:  M L Lorente; M Falguera; A Nogués; A R González; M T Merino; M R Caballero
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.

Authors:  G W Waterer; R G Wunderink
Journal:  Respir Med       Date:  2001-01       Impact factor: 3.415

4.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

5.  Feasibility of real-time polymerase chain reaction in whole blood to identify Streptococcus pneumoniae in patients with community-acquired pneumonia.

Authors:  Cordelia Kee; Silvano Palladino; Ian Kay; Todd M Pryce; Ronan Murray; Jordi Rello; Miquel Gallego; Manel Lujan; Carmen Muñoz-Almagro; Grant W Waterer
Journal:  Diagn Microbiol Infect Dis       Date:  2008-01-24       Impact factor: 2.803

6.  Meningococcal bacterial DNA load at presentation correlates with disease severity.

Authors:  S J Hackett; M Guiver; J Marsh; J A Sills; A P J Thomson; E B Kaczmarski; C A Hart
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

7.  Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples.

Authors:  Miquel Falguera; Aurora López; Antoni Nogués; José Manuel Porcel; Manuel Rubio-Caballero
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

8.  Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy.

Authors:  C J Grace; J Lieberman; K Pierce; B Littenberg
Journal:  Clin Infect Dis       Date:  2001-04-30       Impact factor: 9.079

9.  Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.

Authors:  C E Corless; M Guiver; R Borrow; V Edwards-Jones; A J Fox; E B Kaczmarski
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

View more
  34 in total

Review 1.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  C-reactive protein in community-acquired sepsis: you can teach new tricks to an old dog.

Authors:  Jorge I F Salluh; Thiago Lisboa
Journal:  Crit Care       Date:  2011-09-07       Impact factor: 9.097

4.  Evaluation of several biochemical and molecular techniques for identification of Streptococcus pneumoniae and Streptococcus pseudopneumoniae and their detection in respiratory samples.

Authors:  Els Wessels; Jacqueline J G Schelfaut; Alexandra T Bernards; Eric C J Claas
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

5.  DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema.

Authors:  Carmen Muñoz-Almagro; Sandra Gala; Laura Selva; Iolanda Jordan; David Tarragó; Roman Pallares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-24       Impact factor: 3.267

6.  Improved sensitivity for molecular detection of bacterial and Candida infections in blood.

Authors:  Andrea Bacconi; Gregory S Richmond; Michelle A Baroldi; Thomas G Laffler; Lawrence B Blyn; Heather E Carolan; Mark R Frinder; Donna M Toleno; David Metzgar; Jose R Gutierrez; Christian Massire; Megan Rounds; Natalie J Kennel; Richard E Rothman; Stephen Peterson; Karen C Carroll; Teresa Wakefield; David J Ecker; Rangarajan Sampath
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

7.  A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection.

Authors:  Alfonso Olaya-Abril; Irene Jiménez-Munguía; Lidia Gómez-Gascón; Ignacio Obando; Manuel J Rodríguez-Ortega
Journal:  Mol Cell Proteomics       Date:  2015-07-16       Impact factor: 5.911

Review 8.  Developments for improved diagnosis of bacterial bloodstream infections.

Authors:  A J M Loonen; P F G Wolffs; C A Bruggeman; A J C van den Brule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-22       Impact factor: 3.267

9.  Diagnostic value of serum pneumococcal DNA load during invasive pneumococcal infections.

Authors:  A J H Cremers; F Hagen; P W M Hermans; J F Meis; G Ferwerda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-22       Impact factor: 3.267

10.  Real-time polymerase chain reaction and culture in the diagnosis of invasive group B streptococcal disease in infants: a retrospective study.

Authors:  M Meehan; M Cafferkey; S Corcoran; A Foran; N Hapnes; D LeBlanc; C McGuinness; U Nusgen; N O'Sullivan; R Cunney; R Drew
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.